Structure Of Enzyme Involved In Gentamicin Resistance Revealed For First Time

A team of scientists, led by researchers from the Howard Hughes Medical Institute (HHMI) at The Rockefeller University, has determined the three-dimensional structure of an enzyme responsible for resistance of certain bacteria to the antibiotic gentamicin. The structure, reported in the August 21 Cell, is the first for this family of antibiotics and presents a possible target for designing drugs to thwart resistance.

"Our structure of this antibiotic-resistance enzyme reveals how remarkably simple proteins can present life-threatening problems for critically ill patients," says senior author Stephen K. Burley, M.D., D.Phil., Richard M. and Isabel P. Furlaud Professor and head of the Laboratory of Molecular Biophysics at Rockefeller. Burley, an HHMI investigator, also directs the university's Center for Biochemistry and Structural Biology.

The enzyme belongs to a family of proteins called aminoglycoside N-acetyltransferases (AATs). AATs catalyze the addition of molecules called acetyl groups to aminoglycoside antibiotics such as gentamicin, tobramycin and netilmicin, which are commonly directed against certain bacteria that are responsible for hospital-acquired infections in people with compromised immune systems. Bacteria acquire AATs and become resistant to these antibiotics through overuse.

The enzyme's structure resembles a cupped right hand wrapped around a cylinder. The cavity produced by the cupped hand, dubbed the gentamicin-binding slot by the researchers, presents a possible target for drugs aimed at thwarting antibiotic resistance.

"We think that this narrow cleft acts as the binding site for gentamicin and holds it in place," says Burley. "When the acetyl group is transferred to the protein, the gentamicin flies off.

These findings open the door for the design of drugs that would inhibit the action of AAT.

Burley's co-authors on the paper are Eva Wolf, Ph.D., and Andrej Sali, Ph.D., at Rockefeller and Alex Vassilev, Ph.D., Yasu

Contact: Joseph Bonner
(212) 327-7900
Rockefeller University

Page: 1 2

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Structure solved by Scripps scientists shows one way that body controls gene expression
3. Structure of a Nobel-prize winning molecule: Aquaporin
4. Structure of HIV-neutralizing antibody solved
5. Structure of key breast cancer receptor determined
6. Structure of cog at the hub of metabolism reveals anti-ageing function
7. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
8. Structure reveals details of cells cargo-carriers
9. Structure of key receptor unlocked; Related proteins will fall like dominoes
10. New Science Press launches Proteins: From Sequence to Structure
11. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment

Post Your Comments:

(Date:8/23/2019)... CHICAGO (PRWEB) , ... August 22, 2019 , ... ... by rebranding to Planet121 following their acquisition in June of 2018. Along with ... logo and communications. , “Our goal was to create a cohesive brand ...
(Date:8/21/2019)... (PRWEB) , ... August 20, 2019 , ... ... experience for the second time since BioInformatics first fielded the survey in 2016. ... Life Science Customer Experience , from BioInformatics, part of Science and Medicine Group. ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... what? As serialization mandates become increasingly complex, and aggregation becomes fully applied in ... software is the best long-term solution. , Until now, most regulations?including the Drug ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ROANOKE, Va. (PRWEB) , ... June 11, 2019 ... ... for microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced ... in virtual care. , Mytonomy recently deployed its virtual care platform ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study ... stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their ... mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. This ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance Seminars today ... 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is always selected ... training will kick off with a compendial treatment of Data Integrity fundamentals. After ...
Breaking Biology Technology:
Cached News: